Magnera Reports Third Quarter Results – Provides Updated Outlook

Rhea-AI Summary

Magnera (NYSE:MAGN) reported its fiscal Q3 2025 results with net sales of $839 million, representing a 51% increase, primarily driven by the Glatfelter merger contributing $320 million. The company posted operating income of $13 million and Adjusted EBITDA of $91 million, up 23% year-over-year.

Despite challenging market conditions, including softness in Europe and competitive pressures in South America leading to a 5% organic volume decline, Magnera confirmed its original free cash flow guidance and adjusted EBITDA range. The company's total debt stands at $1.999 billion with a leverage ratio of 3.9x, while maintaining $276 million in cash.

The company continues to focus on value creation through Project CORE (Capacity Optimization and Resource Efficiency program) and merger synergy commitments.

Positive

• Net sales increased 51% to $839 million, primarily due to Glatfelter merger contribution
• Adjusted EBITDA grew 23% to $91 million year-over-year
• Strong cash position with $276 million in cash and cash equivalents
• Company confirmed original free cash flow guidance and adjusted EBITDA range

Negative

• Operating income declined to $13 million from $17 million year-over-year
• 5% organic volume decline due to European market softness and South American competitive pressures
• High leverage ratio at 3.9x with total debt of $1.999 billion
• Net loss of $18 million or ($0.51) per share compared to $19 million profit last year

Insights

Financial Analyst

Magnera reports mixed Q3 results with revenue growth from merger but organic decline; maintains guidance despite challenges.

Magnera's Q3 2025 results reveal a complex financial picture with both strengths and challenges. The company reported $839 million in net sales, representing a 51% year-over-year increase, but this growth primarily stems from the $320 million contribution from the Glatfelter merger rather than organic growth. In fact, the company experienced a concerning 5% organic volume decline attributed to European market softness and competitive pressures from imports in South America.

The operating income of $13 million decreased from $17 million in the prior year, indicating margin compression. Meanwhile, adjusted EBITDA increased 23% to $91 million, but on a comparable basis (normalizing for merger effects), adjusted EBITDA actually declined 9%.

A deeper examination of segment performance shows continued challenges. The Americas segment faced a 6% organic volume decline, while the Rest of World segment saw a 3% decline. The price/cost spread was unfavorable by $3 million overall and $5 million specifically in the Americas segment, suggesting limited pricing power in current market conditions.

The balance sheet reveals a substantial debt position of $1.999 billion against $276 million in cash, resulting in net debt of $1.723 billion and a leverage ratio of 3.9x. This leverage level warrants monitoring, though management has explicitly committed to debt reduction as a priority.

Despite these challenges, management has maintained its original free cash flow guidance and adjusted EBITDA range. The company's focus on its Capacity Optimization and Resource Efficiency program (Project CORE) and merger synergies suggests recognition of the need to improve operational efficiency in the face of volume and pricing pressures. The $45 million in post-merger adjusted free cash flow year-to-date provides some financial flexibility, but the negative $13 million free cash flow in the quarter itself indicates potential near-term cash constraints.

The market will likely focus on whether Magnera can successfully navigate these challenging conditions through its efficiency initiatives while addressing the underlying organic volume declines across both major segments.

Third Quarter Highlights

• GAAP: Net sales of $839 million, Operating income of $13 million
• Non-GAAP: Adjusted EBITDA of $91 million
• Confirming post-merger adjusted free cash flow and Adjusted EBITDA range
  

CHARLOTTE, N.C., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Magnera (NYSE: MAGN), a global leader in specialty materials for the consumer products and personal care markets, today reported financial results for its fiscal 2025 third quarter ended June 28, 2025. Curt Begle, Magnera’s CEO, commented: “Reflecting on the third quarter, I am pleased with our progress and what we have achieved in these challenging market conditions. We are confirming our original free cash flow guidance as well as the range of adjusted EBITDA communicated in our second quarter earnings call.

Looking ahead, we are energized by the value creation opportunities before us. By accelerating revenue through our sales and innovation pipelines, executing our Capacity Optimization and Resource Efficiency program (Project CORE), and delivering on our synergy commitments, we are confident in our ability to drive long-term sustainable growth.

I am incredibly proud of our team’s continued passion, resilience, and accountability. Their unwavering focus on exceeding customer expectations has been instrumental to our success this quarter and reflects the strength of our business.”

Key Financials

				June Quarter				June YTD
GAAP results					2025		2024		2025		2024
Net sales				$	839	$	556	$	2,365	$	1,633
Operating income					13		17		(5)		26

	June Quarter				Reported	Comparable(1)	June YTD				Reported	Comparable(1)
Adjusted non-GAAP results		2025		2024	Δ %	Δ %		2025		2024	Δ %	Δ %
Net sales	$	839	$	556	51%	(5%)	$	2,365	$	1,633	45%	(4%)
Adjusted EBITDA (1)		91		74	23%	(9%)		264		216	22%	(4%)

(1)

Adjusted non-GAAP results exclude items not considered to be ongoing operations. In addition, comparable change % normalizes the impacts of foreign currency and the recent merger with GLT. Further details related to non-GAAP measures and reconciliations can be found under our “Reconciliation of Non-GAAP Financial Measures and Estimates” section or in reconciliation tables in this release. Dollars in millions

Consolidated Overview

The net sales increase of 51% included revenue from the Glatfelter merger of $320 million that was partially offset by a $7 million decrease in selling prices and a 5% organic volume decline which was attributed to general market softness in Europe and competitive pressures from imports in South America.

The adjusted EBITDA increase of 23% included a contribution from the Glatfelter merger of $23 million partially offset by unfavorable impacts from a $4 million volume decline and $3 million from price/cost spread.

Americas

The net sales increase in the Americas segment included revenue from the Glatfelter merger of $124 million partially offset by decreased selling prices of $8 million, unfavorable foreign currency changes of $9 million, and a 6% organic volume decline, which was primarily attributed to competitive pressures from imports in South America.

The adjusted EBITDA increase included a contribution from the Glatfelter merger of $10 million partially offset by unfavorable impacts from price cost spread of $5 million and volume decline of $3 million.

Rest of World

The net sales increase in the Rest of World segment included revenue from the Glatfelter merger of $196 million and a $7 million favorable impact from foreign currency changes partially offset by a 3% organic volume decline which was primarily attributed to general market softness in Europe.

The adjusted EBITDA increase included a contribution from the Glatfelter merger of $13 million.

Free Cash Flow and Net Debt

Magnera is committed to strengthening our credit metrics by paying down debt in the near term.

(in millions)		June Quarter			June YTD
Cash flow from operating activities		$	-		$	7
Pre-merger cash flow from operating activities			-			90
Additions to property, plant and equipment, net			(13	)		(52	)
Post-merger adjusted free cash flow (1)		$	(13	)	$	45
(1)	Further details related to non-GAAP measures and reconciliations can be found under our “Reconciliation of Non-GAAP Financial Measures and Estimates” section or in reconciliation tables in this release.
(in millions)		June 28, 2025
Term Loan		$	781
4.75% First Priority Senior Secured Notes			500
7.25% First Priority Senior Secured Notes			800
Debt discount, deferred fees and other (net)			(82	)
Total debt		$	1,999
Cash and cash equivalents			276
Total net debt		$	1,723
Leverage			3.9x

Investor Conference Call

The Company will host a conference call today, August 6, 2025, at 10:00 a.m. U.S. Eastern Time to discuss our June 2025 quarter results. The webcast can be accessed here. A replay of the webcast will be available via the same link on our website after the completion of the call.

By Telephone
Participants may register for the call here now or any time up to and during the time of the call and will immediately receive the dial-in number and a unique pin to access the call. While you may register at any time up to and during the time of the call, you are encouraged to join the call 15 minutes prior to the start of the event.

About Magnera

Magnera Corporation (NYSE: MAGN) serves 1,000+ customers worldwide, offering a wide range of material solutions, including components for absorbent hygiene products, protective apparel, wipes, specialty building and construction products, and products serving the food and beverage industry. Operating across 46 global facilities, Magnera is supported by over 9,000 employees. Magnera’s purpose is to better the world with new possibilities made real. For more than 160 years, the company has delivered the material solutions their partners need to thrive. Through economic upheaval, global pandemics and changing end-user needs, we have consistently found ways to solve problems and exceed expectations. The distinct scale and comprehensive portfolio of products brings customers more materials and choices. Magnera builds personal partnerships that withstand an ever-changing world.

Visit Magnera.com for more information and follow @MagneraCorporation on social platforms.

Non-GAAP Financial Measures and Estimates
This press release includes non-GAAP financial measures including, but not limited to, Adjusted EBITDA, free cash flow, and comparable basis net sales and adjusted EBITDA. A reconciliation of these non-GAAP financial measures to comparable measures determined in accordance with accounting principles generally accepted in the United States of America (GAAP) is set forth at the end of this press release. Information reconciling forward-looking adjusted EBITDA and adjusted free cash flow are not provided because such information is not available without unreasonable effort due to high variability, complexity, and low visibility with respect to certain items, including debt refinancing activity or other non-comparable items. These items are uncertain, depend on various factors, and could be material to our results computed in accordance with U.S. GAAP.

Forward Looking Statements

Information included or incorporated by reference in Magnera Corporation’s filings with the U.S. Securities and Exchange Commission (the “SEC”) and press releases or other public statements contains or may contain “forward-looking” statements within the meaning of the federal securities laws and are presented pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such “forward-looking” statements include, but are not limited to, statements with respect to our financial condition, results of operations and business, our expectations or beliefs concerning future events, statements about the benefits of the transaction between Glatfelter Corporation and Berry Global Group, Inc., including future financial and operating results, the combined company’s plans, objectives, expectations and intentions, and other statements that are not historical facts. These statements contain words such as “believes,” “expects,” “may,” “will,” “should,” “would,” “could,” “seeks,” “approximately,” “intends,” “plans,” “estimates,” “projects,” “outlook,” “anticipates” or “looking forward” or similar expressions that relate to our strategy, plans, intentions, or expectations. All statements we make relating to our estimated and projected earnings, margins, costs, expenditures, cash flows, growth rates, and financial results or to our expectations regarding future industry trends are forward-looking statements. In addition, we, through our senior management, from time to time make forward-looking public statements concerning our expected future operations and performance and other developments. These forward-looking statements are based upon the current beliefs and expectations of the management of Magnera and are subject to risks and uncertainties that may change at any time, and, therefore, our actual results may differ materially from those that we expected. These risks and other risk factors are detailed from time to time in Magnera’s reports filed with the Securities and Exchange Commission (the “SEC”), including annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, including our Form 8-K/A filed on January 31, 2025, and other documents filed with the SEC. These risk factors may not contain all of the material factors that are important to you. New factors may emerge from time to time, and it is not possible to either predict new factors or assess the potential effect of any such new factors. Accordingly, readers should not place undue reliance on those statements. All forward-looking statements are based upon information available as of the date hereof. All forward-looking statements are made only as of the date hereof, and we undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.

Consolidated and Combined Statements of Income (Unaudited)

	Quarterly Period Ended											Three Quarterly Periods Ended
(in millions)	June 28, 2025					June 29, 2024						June 28, 2025			June 29, 2024
Net sales	$	839				$	556					$	2,365		$	1,633
Cost of goods sold		749					489						2,116			1,454
Selling, general and administrative		50					26						141			82
Amortization of intangibles		13					12						41			36
Transaction and other activities		14					4						69			18
Corporate expense allocation		-					8						3			17
Operating income (loss)		13					17						(5	)		26
Other expense (income)		-					-						26			(1	)
Interest expense		37					1						102			3
Income (loss) before income taxes		(24			)		16						(133	)		24
Income tax (benefit) expense		(6			)		(3		)				(14	)		(1	)
Net income (loss)	$	(18			)	$	19					$	(119	)	$	25
Basic and diluted net income per share	$	(0.51			)	$	0.60					$	(3.35	)	$	0.79
Outstanding weighted average shares
Basic and diluted		35.6					31.8						35.5			31.8

Condensed Consolidated and Combined Statements of Cash Flows (Unaudited)

	Three Quarterly Periods Ended
(in millions)	June 28, 2025				June 29, 2024
Net cash from (used in) operating activities		7				31
Cash flows from investing activities:
Additions to property, plant, and equipment, net		(52	)			(56	)
Cash acquired from GLT acquisition		37				-
Other investing activities		22				29
Net cash from (used in) investing activities		7				(27	)
Cash flows from financing activities:
Proceeds from long-term borrowings		1,556				-
Repayments on long-term borrowings		(434	)			(3	)
Transfers from (to) Berry, net		34				(8	)
Cash distribution to Berry		(1,111	)			-
Debt fees and other, net		(17	)			-
Net cash from financing activities		28				(11	)
Effect of currency translation on cash		4				(2	)
Net change in cash and cash equivalents		46				(9	)
Cash and cash equivalents at beginning of period		230				185
Cash and cash equivalents at end of period	$	276			$	176

Condensed Consolidated Balance Sheets (Unaudited)

(in millions of USD)	June 28, 2025			September 28, 2024
Cash and cash equivalents		$	276	$	230
Accounts receivable			517		359
Inventories			535		259
Other current assets			156		38
Property, plant, and equipment			1,532		949
Goodwill, intangible assets, and other long-term assets			1,096		972
Total assets		$	4,112	$	2,807
Current liabilities, excluding current debt			576		457
Current and long-term debt			1,999		-
Other long-term liabilities			406		211
Stockholders’ equity			1,131		2,139
Total liabilities and stockholders' equity		$	4,112	$	2,807

Reconciliation of Non-GAAP Measures and Estimates
(in millions of dollars)

Reconciliation of Net sales and Adjusted EBITDA on a supplemental comparable basis by segment
		Quarterly Period ended June 28, 2025											Quarterly Period ended June 29, 2024
		Americas				Rest of World				Total					Americas				Rest of World				Total
Net sales		$	473			$	366			$	839				$	388			$	168			$	556
Constant FX rates																(9)				7				(2)
GLT prior year																127				202				329
Comparable net sales (1)(6)		$	473			$	366			$	839				$	506			$	377			$	883
Operating Income		$	12			$	1			$	13				$	16			$	1			$	17
Depreciation and amortization			35				23				58					30				12				42
Transaction, business consolidation and other activities (2)			9				4				13					4				-				4
Impact from hyperinflation			1				-				1					-				-				-
GAAP carve-out allocation (3)			-				-				-					6				2				8
Other non-cash charges (5)			4				2				6					2				-				2
Adjusted EBITDA (1)		$	61			$	30			$	91				$	59			$	15			$	74
Constant FX rates																-				-				-
GLT prior year																11				15				26
Comparable Adjusted EBITDA (1)(6)		$	61			$	30			$	91				$	70			$	30			$	100
% vs. prior year comparable			(13%)				0%				(9%)
		Three Quarterly Periods ended June 28, 2025											Three Quarterly Periods ended June 29, 2024
		Americas				Rest of World				Total					Americas				Rest of World				Total			LTM
Net sales		$	1,366			$	999			$	2,365				$	1,111			$	522			$	1,633
Constant FX rates																(37)				(5)				(42)
GLT prior year																329				539				868
Comparable net sales (1)(6)		$	1,366			$	999			$	2,365				$	1,403			$	1,056			$	2,459
Operating Income		$	13			$	(18)			$	(5)				$	33			$	(7)			$	26		$	(172)
Depreciation and amortization			107				62				169					91				39				130			214
Transaction, business consolidation and other activities (2)			43				21				64					10				8				18			75
Impact from hyperinflation			1				-				1					15				-				15			1
Goodwill impairment			-				-				-					-				-				-			172
GAAP carve-out allocation (3)			2				1				3					14				3				17			7
Other non-cash charges (4)(5)			15				17				32					6				4				10			33
Adjusted EBITDA (1)		$	181			$	83			$	264				$	169			$	47			$	216		$	330
Constant FX rates																(6)				(1)				(7)
GLT prior year																26				41				67
Comparable Adjusted EBITDA (1)(6)		$	181			$	83			$	264				$	189			$	87			$	276
% vs. prior year comparable			(4%)				(5%)				(4%)
PF GLT Adjusted EBITDA (3)											8													8			33
Synergies and cost reductions																											75
PF Adjusted EBITDA																										$	438

(1)	Supplemental financial measures that are not required by, or presented in accordance with, accounting principles generally accepted in the United States (“GAAP”). These non-GAAP financial measures should not be considered as alternatives to operating or net income or cash flows from operating activities, in each case determined in accordance with GAAP. Comparable basis measures exclude the impact of currency translation effects and acquisitions. These non-GAAP financial measures may be calculated differently by other companies, including other companies in our industry, limiting their usefulness as comparative measures. Management believes that Adjusted EBITDA and other non-GAAP financial measures are useful to our investors because they allow for a better period-over-period comparison of operating results by removing the impact of items that, in management’s view, do not reflect our core operating performance. We define “Post-merger free cash flow” as cash flow from operating activities, less pre-merger free cash flow, less net additions to property, plant, and equipment. We believe free cash flow is useful to an investor in evaluating our liquidity because free cash flow and similar measures are widely used by investors, securities analysts, and other interested parties in our industry to measure a company’s liquidity. We believe post-merger free cash flow is also useful to an investor in evaluating our liquidity as it can assist in assessing a company’s ability to fund its growth through its generation of cash and as pre-merger cash flow is not indicative of our current structure and operations. We also use Adjusted EBITDA and comparable basis measures, among other measures, to evaluate management performance and in determining performance-based compensation. Adjusted EBITDA is a measure widely used by investors, securities analysts, and other interested parties in our industry to measure a company’s performance. We also believe these measures are useful to an investor in evaluating our performance without regard to revenue and expense recognition, which can vary depending upon accounting methods.
(2)	Includes restructuring, business optimization and other charges and YTD balance also includes $19 million of transaction compensation
(3)	Consists of estimated parent-allocated charges for the period prior to merger which is required by GAAP as part of the carve-out financial statement process.
(4)	Includes a $12 million inventory step-up charge related to GLT merger YTD and other non-cash charges.
(5)	Includes stock compensation expense and equipment disposals
(6)	The prior year comparable basis change excludes the impacts of foreign currency and acquisition/mergers.

IR Contact Information
Robert Weilminster
EVP, Investor Relations
IR@magnera.com

FAQ

What were Magnera's (MAGN) key financial results for Q3 2025?

Magnera reported net sales of $839 million, operating income of $13 million, and Adjusted EBITDA of $91 million. The company posted a net loss of $18 million or ($0.51) per share.

How did the Glatfelter merger impact Magnera's Q3 2025 results?

The Glatfelter merger contributed $320 million to net sales and $23 million to adjusted EBITDA in Q3 2025.

What is Magnera's current debt position as of Q3 2025?

Magnera's total debt stands at $1.999 billion with a leverage ratio of 3.9x. The company maintains $276 million in cash and cash equivalents.

What were the main challenges Magnera faced in Q3 2025?

Magnera experienced a 5% organic volume decline due to general market softness in Europe and competitive pressures from imports in South America.

What is Project CORE at Magnera?

Project CORE is Magnera's Capacity Optimization and Resource Efficiency program aimed at driving long-term sustainable growth through operational improvements.